ArticleCancer chemotherapy and pharmacology2020
Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.
Samuel J Reddick et al.PubMed ↗Publisher ↗
No numbers read from the abstract.